Canopy Growth (TSX:WEED): Is This Stock the Ultimate Long-Term Bet?

Is Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock a good investment after the recent pullback?

| More on:
question marks written reminders tickets

Image source: Getty Images

Cannabis investors have been on a roller-coaster ride in the last year. Just before Canada legalized cannabis consumption for recreational use, cannabis stocks were trading close to all-time highs. Since then, markets have been choppy, and investors have experienced extreme volatility.

Shares of Canopy Growth (TSX:WEED)(NYSE:CGC) have mirrored the markets. The stock was trading $76.68 per share back in October 2018 and has lost 43.1% in market value since then.

So, is it time for Canopy Growth shares to bounce back? Well, the company has experienced a pullback recently after its CEO and founder Bruce Linton was dismissed by the board of directors. Linton had built Canopy Growth to a $20 billion giant. But the board was unimpressed by Canopy’s piling losses.

The cannabis industry has also failed to gain investor confidence, and several experts have raised questions about corporate governance in this business. The recent scandal of CannTrust has exasperated these concerns. The Canadian Marijuana Index too is down over 30% since April this year.

Are negative profits a huge concern for Canopy Growth?

Canopy Growth has seen a stellar rise in revenue over the years. Its sales have risen from $40 million in fiscal 2017 (year ended in March) to $78 million in 2018 and $253 million in 2019. Analysts now estimate sales to reach $729 million in 2020, $1.32 billion in 2022, and $2.13 billion in 2023. This would imply an annual growth rate of over 100%.

But Canopy has failed to improve the bottom line, and this has left investors unhappy. Canopy Growth’s losses have increased over time. The company posted a net loss of $17 million in 2017. This rose to $70 million in 2018 and a staggering $685 million in 2019. Canopy’s profit margins will get better going forward.

Its losses will narrow to $524 million in 2020 and $76 million in 2021. Analysts expect the company to post a net profit of $309 million in 2022, indicating a healthy net margin of 14.5%.

Canopy Growth had raised $526 million via a stock issue in fiscal 2018. It also raised $5.2 billion in another stock issue in, while $600 million was raised in a debt issue in fiscal 2019. While this will dilute investor holding, stakeholders will not mind as long as Canopy Growth can continue to exponentially grow sales and expand profit margins.

The new CEO will be backed by Constellation Brands

Canopy Growth is also looking for a new CEO. There are speculations that the position will be filled in by Constellation Brands’s leadership team. Constellation Brands had invested $5 billion in Canopy Growth and has a 38% stake in the company. This is likely to boost investor confidence and will mean that Constellation Brands is all-in.

The verdict

Canopy Growth shares were overvalued when it was trading at $76 per share last year. The stock has corrected significantly and might still experience some volatility. However, the cannabis industry is a fast-growing market. Canopy Growth is a major player here and is consolidating its position in international markets. It also has a huge opportunity to grow inorganically.

If Canopy Growth can stay away from controversies and improve margins in line with estimates, this stock will generate significant investor returns. Constellation Brands is betting on Canopy Growth big time. While no one can predict when the stock bottoms out, it would be advisable to keep increasing positions on major dips.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Forget Canopy Growth: 1 Cannabis Stock With Far Less Risk

Cannabis stocks like Canopy Growth (TSX:WEED) haven't done well for quite some time, yet this one deserves a major boost!

Read more »